A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement
Condition: Post Operative Pain Interventions: Drug: F14; Drug: 0.25 % Bupivacaine HCl; Drug: Acetaminophen; Drug: Methocarbamol Sponsors: Arthritis Innovation Corporation; Allucent Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acetaminophen | Lortab | Methocarbamol | Pain | Pain Management | Research | Rheumatology | Study